Media Statement Regarding Provincial CTS Decision
The following statement is issued on behalf Dr. Ken Blanchette, CEO of the Windsor-Essex County Health Unit:
The following statement is issued on behalf Dr. Ken Blanchette, CEO of the Windsor-Essex County Health Unit:
If you or someone you care about is struggling with alcohol, cannabis, or other substance use, find the right help.
As the opioid crisis in Canada continues to escalate, youth need information to make informed decisions about harm-reduction substance use strategies versus an abstinence only approach.
Rising rates of opioid-related overdose and death continue to be a concern for local health and social services leaders working on the Windsor-Essex Community Opioid and Substance Strategy.
In October 2018, after a provincial review of existing Supervised Consumption Services (SCS) and Overdose Prevention Sites (OPS), the Government of Ontario announced its commitment to fund a re-purposed version of the Consumption and Treatments Services (CTS) Program. Consumption and Treatment Services sites provide wrap-around services that connect clients who use drugs to primary care, treatment, and other health and social services; including:
Mental illness can be defined as a condition that is characterized by alterations in mood, thinking, and/or behaviour, and associated with symptoms of significant distress and decreased functioning. There are a wide variety of mental illnesses, ranging from mood disorders, anxiety disorders, personality disorders, eating disorders, schizophrenia, problem gambling, and substance use disorders.
If you or someone you care about is using opioids in any form, it is important to have a Naloxone Nasal Spray kit to prevent injury or death associated with an opioid poisoning (overdose).An opioid poisoning (overdose) is a medical emergency and 9-1-1 should be called any time naloxone is administered. When a person regains consciousness after receiving naloxone, they may become irritable, restless, or exhibit aggressive behaviour. If at anytime you feel your safety is at risk, you should remove yourself from the situation and call for assistance.
As part of the Ontario Harm Reduction Program Enhancement, the ONP has expanded access to free naloxone nasal spray kits for clients who are at high risk of an opioid overdose as well as their friends and family.
Naloxone is a fast-acting medication that can temporarily reverse the effects of an opioid overdose. The Windsor-Essex County Health Unit (WECHU) is committed to increasing access to harm reduction services to prevent opioid overdose-related deaths.
Starting June 1, 2023, employers must provide naloxone in the workplace if certain circumstances described in the Occupational Health and Safety Act apply. To learn more, visit the Government of Ontario’s Naloxone in the Workplace webpage.
Eligible organizations include Community Health Centers, Outreach Organizations, Shelters, Aboriginal Health Access Centres, HIV/AIDS service organizations, Withdrawal Management programs, and organizations eligible through expanded access who work directly with clients who may be at risk of an opioid overdose. To determine if your organization falls into the outreach or withdrawal management program categories, your organization must meet the following criteria:
If you are interested in becoming an ONP Community partner, please submit an online Statement of Need.
The Health Unit will provide free training and resources to administer and dispense naloxone to your clients. This means that a minimum of one staff member from each agency must receive training from WECHU. The remaining staff must be trained using the train-the-trainer guide provided by WECHU. The training provided by WECHU will encompass recognizing and responding to an overdose, naloxone administration, naloxone distribution, online data entry, storage and handling of naloxone and ordering protocols.
By signing a Service Agreement for naloxone distribution, an agency is committing to:
Should you have any questions, please do not hesitate to contact the WECHU, at 519-258-2146, ext. 3200, or email naloxone@wechu.org.
The goal of this consultation is to better understand the needs of our community. We want to know what the community thinks about SIS and identify any concerns that the community may have.